Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)

NCT04073407 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor has determined that information it would have collected would not inform future development of a therapy with AXA 1957 for NAFLD

Conditions

Interventions

Sponsor

Axcella Health, Inc